Evidence map›Paper›PMID 39202212›Full record

ArticleDiagnostics (Basel, Switzerland)2024

The Usefulness of Line-Field Confocal Optical Coherence Tomography in Monitoring Epidermal Changes in Atopic Dermatitis in Response to Treatment: A Pilot Study.

Zuzanna Dryżałowska, Leszek Blicharz, Agnieszka Michalczyk, Jan Koscian, Małgorzata Maj, Joanna Czuwara, Lidia Rudnicka

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zuzanna DryżałowskaDepartment of Dermatology, Medical University of Warsaw, 02-088 Warsaw, Poland.
Leszek BlicharzDepartment of Dermatology, Medical University of Warsaw, 02-088 Warsaw, Poland.ORCID 0000-0002-7633-4168
Agnieszka MichalczykDepartment of Dermatology, Medical University of Warsaw, 02-088 Warsaw, Poland.ORCID 0000-0002-2191-1466
Jan KoscianDepartment of Dermatology, Medical University of Warsaw, 02-088 Warsaw, Poland.ORCID 0009-0005-2769-8714
Małgorzata MajDepartment of Dermatology, Medical University of Warsaw, 02-088 Warsaw, Poland.
Joanna CzuwaraDepartment of Dermatology, Medical University of Warsaw, 02-088 Warsaw, Poland.
Lidia RudnickaDepartment of Dermatology, Medical University of Warsaw, 02-088 Warsaw, Poland.ORCID 0000-0002-8308-1023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtopic dermatitis (AD) is the most common chronic inflammatory skin disease. Due to its high prevalence, considerable morbidity, and chronicity, there is a need for the accurate in vivo evaluation of treatment efficacy. Line-field confocal optical coherence tomography (LC-OCT) is a new emerging imaging technique able to perform a non-invasive, real-time examination of the epidermis and the upper dermis. LC-OCT may represent a promising tool in the diagnosis and treatment follow-up of chronic eczematous skin diseases with barrier defects.

objectivesWe aimed to investigate the role of LC-OCT in the non-invasive monitoring of the treatment effect on five patients with severe atopic dermatitis during dupilumab treatment. MATERIALS AND

methodsLC-OCT imaging was performed on five patients (three women and two men) aged between 14 and 85 years old at the baseline and at 2, 4, and 6 weeks of treatment with dupilumab. The LC-OCT scans were performed at two sites, the lesional skin in the antecubital fossa and the extensor part of the arm, considered a control site on each patient for comparison. The captured images were later evaluated. Descriptive statistics and a

resultsThe LC-OCT imaging was able to detect the difference in stratum corneum (SC) thickness and quality and epidermal thickness (ET) and the changes before and after treatment with high accuracy. The main findings include a significant reduction in the epidermal and stratum corneum thickness and decreased epidermal spongiosis and inflammation, with better quality of the stratum corneum indicating restoration of its tightness at both lesional and control sites.

conclusionsThis study demonstrates that clinical improvement of affected and unaffected atopic skin under dupilumab treatment correlates with the LC-OCT findings. LC-OCT represents a novel, non-invasive tool examining the in vivo skin barrier and inflammation and can help to monitor the treatment efficacy among patients with atopic dermatitis in daily practice.

Indexed as

atopic dermatitisdupilumabline-field confocal optical coherence tomographynon-invasive imagingtreatment monitoring

Identifiers

PMID39202212
PMCPMC11353726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.